IL163525A0 - A follistatin domain containing protein - Google Patents
A follistatin domain containing proteinInfo
- Publication number
- IL163525A0 IL163525A0 IL16352503A IL16352503A IL163525A0 IL 163525 A0 IL163525 A0 IL 163525A0 IL 16352503 A IL16352503 A IL 16352503A IL 16352503 A IL16352503 A IL 16352503A IL 163525 A0 IL163525 A0 IL 163525A0
- Authority
- IL
- Israel
- Prior art keywords
- containing protein
- domain containing
- follistatin domain
- follistatin
- protein
- Prior art date
Links
- 102000016970 Follistatin Human genes 0.000 title 1
- 108010014612 Follistatin Proteins 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/06—Anabolic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Neurology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Marine Sciences & Fisheries (AREA)
- Emergency Medicine (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Dermatology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35784502P | 2002-02-21 | 2002-02-21 | |
US43464402P | 2002-12-20 | 2002-12-20 | |
PCT/US2003/005151 WO2003072715A2 (fr) | 2002-02-21 | 2003-02-21 | Proteine contenant un domaine de follistatine |
Publications (1)
Publication Number | Publication Date |
---|---|
IL163525A0 true IL163525A0 (en) | 2005-12-18 |
Family
ID=27767536
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16352503A IL163525A0 (en) | 2002-02-21 | 2003-02-21 | A follistatin domain containing protein |
Country Status (12)
Country | Link |
---|---|
US (4) | US7192717B2 (fr) |
EP (1) | EP1572909A4 (fr) |
JP (2) | JP4429729B2 (fr) |
KR (1) | KR20040094709A (fr) |
AU (1) | AU2003217612A1 (fr) |
BR (1) | BR0307907A2 (fr) |
CA (1) | CA2476887A1 (fr) |
IL (1) | IL163525A0 (fr) |
MX (1) | MXPA04008150A (fr) |
NO (1) | NO20043886L (fr) |
PL (1) | PL375045A1 (fr) |
WO (1) | WO2003072715A2 (fr) |
Families Citing this family (135)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI329129B (en) | 2001-02-08 | 2010-08-21 | Wyeth Corp | Modified and stabilized gdf propeptides and uses thereof |
US7320789B2 (en) * | 2001-09-26 | 2008-01-22 | Wyeth | Antibody inhibitors of GDF-8 and uses thereof |
EP1572909A4 (fr) * | 2002-02-21 | 2007-06-06 | Wyeth Corp | Proteine contenant un domaine de follistatine |
MXPA04008149A (es) * | 2002-02-21 | 2005-06-17 | Wyeth Corp | Proteinas que contienen dominios de folistatina. |
JP2006507356A (ja) * | 2002-09-16 | 2006-03-02 | ワイエス | ミオスタチンのメタロプロテアーゼ活性化およびミオスタチン活性の調節方法 |
AR047392A1 (es) | 2002-10-22 | 2006-01-18 | Wyeth Corp | Neutralizacion de anticuerpos contra gdf 8 y su uso para tales fines |
US20040223966A1 (en) * | 2002-10-25 | 2004-11-11 | Wolfman Neil M. | ActRIIB fusion polypeptides and uses therefor |
JP5110877B2 (ja) * | 2003-06-02 | 2012-12-26 | ワイス・エルエルシー | 神経筋障害を処置するための、コルチコステロイドと組み合わせたミオスタチン(gdf8)インヒビターの使用 |
DE202004021953U1 (de) | 2003-09-12 | 2013-06-19 | Vessix Vascular, Inc. | Auswählbare exzentrische Remodellierung und/oder Ablation von atherosklerotischem Material |
JP4688483B2 (ja) * | 2004-04-15 | 2011-05-25 | 株式会社テクノネットワーク四国 | フォリスタチン変異体ポリペプチド |
US7670595B2 (en) * | 2004-06-28 | 2010-03-02 | Merck Patent Gmbh | Fc-interferon-beta fusion proteins |
EP3489257A1 (fr) * | 2004-07-23 | 2019-05-29 | Acceleron Pharma Inc. | Polypeptides du récepteur actrii, procédés et compositions |
CN101001642A (zh) * | 2004-08-12 | 2007-07-18 | 惠氏公司 | 使用gdf-8抑制剂对糖尿病、肥胖症和心血管病的联合治疗 |
US7294484B2 (en) | 2004-08-27 | 2007-11-13 | Wyeth Research Ireland Limited | Production of polypeptides |
TWI374935B (en) | 2004-08-27 | 2012-10-21 | Pfizer Ireland Pharmaceuticals | Production of α-abeta |
US7300773B2 (en) | 2004-08-27 | 2007-11-27 | Wyeth Research Ireland Limited | Production of TNFR-Ig |
US9713730B2 (en) | 2004-09-10 | 2017-07-25 | Boston Scientific Scimed, Inc. | Apparatus and method for treatment of in-stent restenosis |
US8396548B2 (en) | 2008-11-14 | 2013-03-12 | Vessix Vascular, Inc. | Selective drug delivery in a lumen |
US20060240487A1 (en) * | 2005-03-23 | 2006-10-26 | Nowak John A | Detection of GDF-8 modulating agents |
AU2006232914A1 (en) * | 2005-03-23 | 2006-10-12 | Wyeth | Detection of an immune response to GDF-8 modulating agents |
WO2007024535A2 (fr) | 2005-08-19 | 2007-03-01 | Wyeth | Anticorps antagonistes contre gdf-8 et utilisations pour le traitement de als et d'autres troubles associes a gdf-8 |
JP5261187B2 (ja) | 2005-11-23 | 2013-08-14 | アクセルロン ファーマ, インコーポレイテッド | アクチビン−ActRIIaアンタゴニストおよび骨成長を促進するための使用 |
US8128933B2 (en) | 2005-11-23 | 2012-03-06 | Acceleron Pharma, Inc. | Method of promoting bone growth by an anti-activin B antibody |
CN101410132A (zh) * | 2006-03-28 | 2009-04-15 | 惠氏公司 | 用于治疗骨疾病的gdf-9/bmp-15调节剂 |
US8019435B2 (en) | 2006-05-02 | 2011-09-13 | Boston Scientific Scimed, Inc. | Control of arterial smooth muscle tone |
EP2076194B1 (fr) | 2006-10-18 | 2013-04-24 | Vessix Vascular, Inc. | Système pour induire des effets thermiques désirables sur un tissu anatomique |
AU2007310986B2 (en) | 2006-10-18 | 2013-07-04 | Boston Scientific Scimed, Inc. | Inducing desirable temperature effects on body tissue |
JP5312337B2 (ja) | 2006-10-18 | 2013-10-09 | べシックス・バスキュラー・インコーポレイテッド | 標的組織の選択的な処置のための調節されたrfエネルギーおよび電気的な組織の特徴付け |
US20100028332A1 (en) * | 2006-12-18 | 2010-02-04 | Acceleron Pharma Inc. | Antagonists of actriib and uses for increasing red blood cell levels |
US8895016B2 (en) * | 2006-12-18 | 2014-11-25 | Acceleron Pharma, Inc. | Antagonists of activin-actriia and uses for increasing red blood cell levels |
CN105797135A (zh) | 2006-12-18 | 2016-07-27 | 阿塞勒隆制药公司 | 活化素-actrii拮抗剂及在提高红细胞水平中的用途 |
US9526759B2 (en) * | 2007-02-01 | 2016-12-27 | Acceleron Pharma Inc. | Activin-actriia antagonists and uses for treating or preventing breast cancer |
TW201940502A (zh) | 2007-02-02 | 2019-10-16 | 美商艾瑟勒朗法瑪公司 | 衍生自ActRIIB的變體與其用途 |
TWI667038B (zh) | 2007-02-09 | 2019-08-01 | 美商艾瑟勒朗法瑪公司 | 包含ActRIIa-Fc融合蛋白的醫藥組合物;ActRIIa-Fc融合蛋白於治療或預防與癌症相關的骨質流失之用途;ActRIIa-Fc融合蛋白於治療或預防多發性骨髓瘤之用途 |
WO2008109779A2 (fr) * | 2007-03-07 | 2008-09-12 | The Johns Hopkins University | Utilisation d'un gène associé à la follistatine-like (flrg) pour accroître la masse musculaire |
EP2207562B1 (fr) * | 2007-09-18 | 2017-05-31 | Acceleron Pharma, Inc. | Antagonistes de l'activine-actriia et utilisations pour réduire ou empêcher la sécrétion de fsh |
US8637455B2 (en) * | 2007-10-22 | 2014-01-28 | Affinergy, Llc | Compositions and methods for delivery of glycopeptide antibiotics to medical device surfaces |
WO2009054967A2 (fr) * | 2007-10-22 | 2009-04-30 | Synthes (U.S.A.) | Compositions pour l'administration d'antibiotiques glycopeptidiques |
PE20091163A1 (es) | 2007-11-01 | 2009-08-09 | Wyeth Corp | Anticuerpos para gdf8 |
JP5778576B2 (ja) * | 2008-06-26 | 2015-09-16 | アクセルロン ファーマ, インコーポレイテッド | アクチビン−ActRIIaアンタゴニストを投薬する方法および処置される患者をモニターする方法 |
FI3750552T3 (fi) | 2008-08-14 | 2023-07-25 | Acceleron Pharma Inc | Gdf-loukkuja |
US8216997B2 (en) | 2008-08-14 | 2012-07-10 | Acceleron Pharma, Inc. | Methods for increasing red blood cell levels and treating anemia using a combination of GDF traps and erythropoietin receptor activators |
EP2355737B1 (fr) | 2008-11-17 | 2021-08-11 | Boston Scientific Scimed, Inc. | Accumulation sélective d énergie sans connaissance de la topographie tissulaire |
CA2749544A1 (fr) | 2009-01-13 | 2010-07-22 | Acceleron Pharma Inc. | Procedes permettant d'augmenter l'adiponectine |
MX2011013172A (es) | 2009-06-08 | 2012-04-02 | Acceleron Pharma Inc | Metodos para aumentar adipocitos termogenicos. |
AU2010263182B2 (en) | 2009-06-12 | 2016-05-12 | Acceleron Pharma Inc. | Truncated ActRIIB-Fc fusion proteins |
EP2475427B1 (fr) * | 2009-09-09 | 2016-11-30 | Acceleron Pharma, Inc. | Antagonistes d'actriib, et dosage et administration associés |
ES2869864T3 (es) * | 2009-11-03 | 2021-10-26 | Acceleron Pharma Inc | Procedimientos para el tratamiento de la enfermedad del hígado graso |
CA2781152A1 (fr) | 2009-11-17 | 2011-05-26 | Acceleron Pharma Inc. | Proteines actriib et variants et utilisations de celles-ci se rapportant a l'induction de l'utrophine pour une therapie de la dystrophie musculaire |
AU2011238925B2 (en) | 2010-04-09 | 2016-06-16 | Vessix Vascular, Inc. | Power generating and control apparatus for the treatment of tissue |
US9192790B2 (en) | 2010-04-14 | 2015-11-24 | Boston Scientific Scimed, Inc. | Focused ultrasonic renal denervation |
WO2011149096A1 (fr) * | 2010-05-27 | 2011-12-01 | 国立大学法人 東京大学 | Médicament améliorant la résistance à l'insuline |
US8473067B2 (en) | 2010-06-11 | 2013-06-25 | Boston Scientific Scimed, Inc. | Renal denervation and stimulation employing wireless vascular energy transfer arrangement |
US9084609B2 (en) | 2010-07-30 | 2015-07-21 | Boston Scientific Scime, Inc. | Spiral balloon catheter for renal nerve ablation |
US9358365B2 (en) | 2010-07-30 | 2016-06-07 | Boston Scientific Scimed, Inc. | Precision electrode movement control for renal nerve ablation |
US9463062B2 (en) | 2010-07-30 | 2016-10-11 | Boston Scientific Scimed, Inc. | Cooled conductive balloon RF catheter for renal nerve ablation |
US9408661B2 (en) | 2010-07-30 | 2016-08-09 | Patrick A. Haverkost | RF electrodes on multiple flexible wires for renal nerve ablation |
US9155589B2 (en) | 2010-07-30 | 2015-10-13 | Boston Scientific Scimed, Inc. | Sequential activation RF electrode set for renal nerve ablation |
CA2807607A1 (fr) | 2010-08-20 | 2012-02-23 | Wyeth Llc | Culture cellulaire de cellules adaptees exemptes de facteur de croissance |
US8974451B2 (en) | 2010-10-25 | 2015-03-10 | Boston Scientific Scimed, Inc. | Renal nerve ablation using conductive fluid jet and RF energy |
US9220558B2 (en) | 2010-10-27 | 2015-12-29 | Boston Scientific Scimed, Inc. | RF renal denervation catheter with multiple independent electrodes |
WO2012064771A1 (fr) | 2010-11-08 | 2012-05-18 | Acceleron Pharma, Inc. | Agents de liaison à actriia et leurs utilisations |
US9028485B2 (en) | 2010-11-15 | 2015-05-12 | Boston Scientific Scimed, Inc. | Self-expanding cooling electrode for renal nerve ablation |
US9089350B2 (en) | 2010-11-16 | 2015-07-28 | Boston Scientific Scimed, Inc. | Renal denervation catheter with RF electrode and integral contrast dye injection arrangement |
US9668811B2 (en) | 2010-11-16 | 2017-06-06 | Boston Scientific Scimed, Inc. | Minimally invasive access for renal nerve ablation |
US9326751B2 (en) | 2010-11-17 | 2016-05-03 | Boston Scientific Scimed, Inc. | Catheter guidance of external energy for renal denervation |
US9060761B2 (en) | 2010-11-18 | 2015-06-23 | Boston Scientific Scime, Inc. | Catheter-focused magnetic field induced renal nerve ablation |
US9192435B2 (en) | 2010-11-22 | 2015-11-24 | Boston Scientific Scimed, Inc. | Renal denervation catheter with cooled RF electrode |
US9023034B2 (en) | 2010-11-22 | 2015-05-05 | Boston Scientific Scimed, Inc. | Renal ablation electrode with force-activatable conduction apparatus |
US20120157993A1 (en) | 2010-12-15 | 2012-06-21 | Jenson Mark L | Bipolar Off-Wall Electrode Device for Renal Nerve Ablation |
US9220561B2 (en) | 2011-01-19 | 2015-12-29 | Boston Scientific Scimed, Inc. | Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury |
AU2012283908B2 (en) | 2011-07-20 | 2017-02-16 | Boston Scientific Scimed, Inc. | Percutaneous devices and methods to visualize, target and ablate nerves |
EP2734264B1 (fr) | 2011-07-22 | 2018-11-21 | Boston Scientific Scimed, Inc. | Système de neuromodulation avec un élément de neuromodulation positionnable dans un guide hélicoïdal |
WO2013055826A1 (fr) | 2011-10-10 | 2013-04-18 | Boston Scientific Scimed, Inc. | Dispositifs médicaux comprenant des électrodes d'ablation |
US10085799B2 (en) | 2011-10-11 | 2018-10-02 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
US9420955B2 (en) | 2011-10-11 | 2016-08-23 | Boston Scientific Scimed, Inc. | Intravascular temperature monitoring system and method |
US9364284B2 (en) | 2011-10-12 | 2016-06-14 | Boston Scientific Scimed, Inc. | Method of making an off-wall spacer cage |
WO2013059202A1 (fr) | 2011-10-18 | 2013-04-25 | Boston Scientific Scimed, Inc. | Cathéter à ballonnet à traversée intégrée |
US9162046B2 (en) | 2011-10-18 | 2015-10-20 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
CA2852021C (fr) | 2011-10-21 | 2018-08-28 | Pfizer Inc. | Ajout de fer pour ameliorer une culture cellulaire |
CN108095821B (zh) | 2011-11-08 | 2021-05-25 | 波士顿科学西美德公司 | 孔部肾神经消融 |
EP2779929A1 (fr) | 2011-11-15 | 2014-09-24 | Boston Scientific Scimed, Inc. | Dispositif et procédés pour surveiller la modulation nerveuse rénale |
US9119632B2 (en) | 2011-11-21 | 2015-09-01 | Boston Scientific Scimed, Inc. | Deflectable renal nerve ablation catheter |
US9265969B2 (en) | 2011-12-21 | 2016-02-23 | Cardiac Pacemakers, Inc. | Methods for modulating cell function |
CA2861622C (fr) | 2011-12-23 | 2020-10-27 | Vessix Vascular, Inc. | Procedes et appareils pour remodeliser un tissu d'un passage corporel ou adjacent a un passage corporel |
WO2013101452A1 (fr) | 2011-12-28 | 2013-07-04 | Boston Scientific Scimed, Inc. | Dispositif et procédés pour la modulation nerveuse à l'aide d'un nouveau cathéter d'ablation doté d'éléments ablatifs polymères |
US9050106B2 (en) | 2011-12-29 | 2015-06-09 | Boston Scientific Scimed, Inc. | Off-wall electrode device and methods for nerve modulation |
WO2013169927A1 (fr) | 2012-05-08 | 2013-11-14 | Boston Scientific Scimed, Inc. | Dispositifs de modulation du nerf rénal |
SA113340642B1 (ar) | 2012-06-15 | 2015-09-15 | فايزر إنك | أجسام مضادة معارضة محسنة ضد gdf-8 واستخداماتها |
RS60318B1 (sr) | 2012-08-01 | 2020-07-31 | Ikaika Therapeutics Llc | Ublažavanje tkivnog oštećenja i fibroze pomoću anti-ltbp4 antitela |
CN104540465A (zh) | 2012-08-24 | 2015-04-22 | 波士顿科学西美德公司 | 带有含单独微孔隙区域的球囊的血管内导管 |
US9173696B2 (en) | 2012-09-17 | 2015-11-03 | Boston Scientific Scimed, Inc. | Self-positioning electrode system and method for renal nerve modulation |
US10398464B2 (en) | 2012-09-21 | 2019-09-03 | Boston Scientific Scimed, Inc. | System for nerve modulation and innocuous thermal gradient nerve block |
WO2014047454A2 (fr) | 2012-09-21 | 2014-03-27 | Boston Scientific Scimed, Inc. | Cathéter d'ablation par ultrasons à refroidissement automatique |
CN104869930B (zh) | 2012-10-10 | 2020-12-25 | 波士顿科学国际有限公司 | 肾神经调制装置和方法 |
EP2914277B1 (fr) | 2012-11-02 | 2017-09-13 | Celgene Corporation | Antagonistes d'activine-actrii et utilisations pour le traitement de troubles osseux et autres |
US9693821B2 (en) | 2013-03-11 | 2017-07-04 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US9956033B2 (en) | 2013-03-11 | 2018-05-01 | Boston Scientific Scimed, Inc. | Medical devices for modulating nerves |
US9808311B2 (en) | 2013-03-13 | 2017-11-07 | Boston Scientific Scimed, Inc. | Deflectable medical devices |
WO2014149690A2 (fr) | 2013-03-15 | 2014-09-25 | Boston Scientific Scimed, Inc. | Dispositifs médicaux et méthodes de traitement de l'hypertension à l'aide d'une compensation d'impédance |
JP6220044B2 (ja) | 2013-03-15 | 2017-10-25 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | 腎神経アブレーションのための医療用デバイス |
US10265122B2 (en) | 2013-03-15 | 2019-04-23 | Boston Scientific Scimed, Inc. | Nerve ablation devices and related methods of use |
US10022182B2 (en) | 2013-06-21 | 2018-07-17 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation having rotatable shafts |
CN105473091B (zh) | 2013-06-21 | 2020-01-21 | 波士顿科学国际有限公司 | 具有可一起移动的电极支撑件的肾脏去神经球囊导管 |
US9707036B2 (en) | 2013-06-25 | 2017-07-18 | Boston Scientific Scimed, Inc. | Devices and methods for nerve modulation using localized indifferent electrodes |
US9833283B2 (en) | 2013-07-01 | 2017-12-05 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
WO2015006480A1 (fr) | 2013-07-11 | 2015-01-15 | Boston Scientific Scimed, Inc. | Dispositifs et procédés de modulation nerveuse |
CN105377170A (zh) | 2013-07-11 | 2016-03-02 | 波士顿科学国际有限公司 | 具有可伸展电极组件的医疗装置 |
WO2015010074A1 (fr) | 2013-07-19 | 2015-01-22 | Boston Scientific Scimed, Inc. | Ballonnet de dénervation rénale à électrode bipolaire en spirale |
EP3024405A1 (fr) | 2013-07-22 | 2016-06-01 | Boston Scientific Scimed, Inc. | Cathéter d'ablation de nerf rénal ayant un ballonnet de torsion |
US10342609B2 (en) | 2013-07-22 | 2019-07-09 | Boston Scientific Scimed, Inc. | Medical devices for renal nerve ablation |
EP4049605A1 (fr) | 2013-08-22 | 2022-08-31 | Boston Scientific Scimed Inc. | Circuit flexible ayant une adhérence améliorée à un ballon de modulation de nerf rénal |
US9895194B2 (en) | 2013-09-04 | 2018-02-20 | Boston Scientific Scimed, Inc. | Radio frequency (RF) balloon catheter having flushing and cooling capability |
EP3043733A1 (fr) | 2013-09-13 | 2016-07-20 | Boston Scientific Scimed, Inc. | Ballonnet d'ablation à couche de revêtement déposée en phase vapeur |
US11246654B2 (en) | 2013-10-14 | 2022-02-15 | Boston Scientific Scimed, Inc. | Flexible renal nerve ablation devices and related methods of use and manufacture |
US9687166B2 (en) | 2013-10-14 | 2017-06-27 | Boston Scientific Scimed, Inc. | High resolution cardiac mapping electrode array catheter |
US9770606B2 (en) | 2013-10-15 | 2017-09-26 | Boston Scientific Scimed, Inc. | Ultrasound ablation catheter with cooling infusion and centering basket |
CN105636537B (zh) | 2013-10-15 | 2018-08-17 | 波士顿科学国际有限公司 | 医疗器械球囊 |
CN105636538B (zh) | 2013-10-18 | 2019-01-15 | 波士顿科学国际有限公司 | 具有柔性导线的球囊导管及其使用和制造的相关方法 |
CN105658163B (zh) | 2013-10-25 | 2020-08-18 | 波士顿科学国际有限公司 | 去神经柔性电路中的嵌入式热电偶 |
JP6382989B2 (ja) | 2014-01-06 | 2018-08-29 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | 耐引き裂き性フレキシブル回路アセンブリを備える医療デバイス |
JP6325121B2 (ja) | 2014-02-04 | 2018-05-16 | ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. | 双極電極上の温度センサの代替配置 |
US11000679B2 (en) | 2014-02-04 | 2021-05-11 | Boston Scientific Scimed, Inc. | Balloon protection and rewrapping devices and related methods of use |
US10010498B2 (en) | 2014-06-04 | 2018-07-03 | Acceleron Pharma Inc. | Methods for treatment of amyotrophic lateral sclerosis with follistatin fusion proteins |
CA2950754C (fr) | 2014-06-04 | 2021-10-26 | Acceleron Pharma, Inc. | Procedes et compositions pour traiter des troubles a l'aide de polypeptides de follistatine |
WO2015192111A1 (fr) | 2014-06-13 | 2015-12-17 | Acceleron Pharma, Inc. | Méthodes et compositions de traitement d'ulcères |
MA41052A (fr) | 2014-10-09 | 2017-08-15 | Celgene Corp | Traitement d'une maladie cardiovasculaire à l'aide de pièges de ligands d'actrii |
MD4801C1 (ro) | 2014-12-03 | 2022-10-31 | Celgene Corporation | Antagonişti ai activin-ActRII şi utilizarea lor pentru tratamentul sindroamelor mielodisplazice |
WO2016120647A2 (fr) | 2015-01-30 | 2016-08-04 | Debreceni Egyetem | Régénération musculaire |
KR20170129233A (ko) * | 2015-03-26 | 2017-11-24 | 악셀레론 파마 인코포레이티드 | 폴리스타틴-관련된 융합 단백질 및 이들의 용도 |
HU230620B1 (hu) | 2015-05-14 | 2017-04-28 | ALU-ÖNTŐ Fémöntő és Fémmegmunkáló Ipari | Eljárás vékonyfalú, tagolt, részletgazdag alumínium öntvények homokformázásos technológiával, gravitációs öntéssel történő előállítására |
EP3423479A2 (fr) * | 2016-03-04 | 2019-01-09 | Shire Human Genetic Therapies, Inc. | Protéines de fusion follistatine-fc recombinantes et leur utilisation dans le traitement de la dystrophie musculaire de duchenne |
EA202092203A1 (ru) * | 2018-03-19 | 2020-12-07 | Ридженерон Фармасьютикалз, Инк. | Способы анализа и реагенты для микрочипового капиллярного электрофореза |
EP3897689A1 (fr) | 2018-12-21 | 2021-10-27 | Northwestern University | Utilisation d'annexines dans la prévention et le traitement d'une lésion de la membrane musculaire |
US20220062299A1 (en) | 2018-12-26 | 2022-03-03 | Northwestern University | Use of glucocorticoid steroids in preventing and treating conditions of muscle wasting, aging and metabolic disorder |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US181033A (en) * | 1876-08-15 | Improvement in fire-kindlers | ||
US43232A (en) * | 1864-06-21 | Improvement in preserving fruits | ||
US223966A (en) * | 1880-01-27 | Vapor-burner | ||
US150577A (en) * | 1874-05-05 | Improvement in grain-separators | ||
US77053A (en) * | 1868-04-21 | Improvement in mitre-gauges | ||
US162714A (en) * | 1875-04-27 | Improvement in balanced and cut-off valves | ||
US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
US6162896A (en) * | 1991-05-10 | 2000-12-19 | The Salk Institute For Biological Studies | Recombinant vertebrate activin receptors |
US5994618A (en) | 1997-02-05 | 1999-11-30 | Johns Hopkins University School Of Medicine | Growth differentiation factor-8 transgenic mice |
US7393682B1 (en) | 1993-03-19 | 2008-07-01 | The Johns Hopkins University School Of Medicine | Polynucleotides encoding promyostatin polypeptides |
DE69432815T2 (de) | 1993-03-19 | 2003-12-11 | Univ Johns Hopkins Med | Wachstumsfaktor-8 |
AU678582B2 (en) | 1993-05-12 | 1997-06-05 | Genetics Institute, Llc | BMP-11 compositions |
EP1716864A1 (fr) * | 1993-08-26 | 2006-11-02 | Genetics Institute, LLC | Régéneration nerveuse utilisant des protéines morphogénetiques osseuses chez l'homme |
CA2194660C (fr) | 1994-07-08 | 2009-09-29 | Se-Jin Lee | Facteur 11 de differentiation de croissance |
US6008434A (en) | 1994-07-08 | 1999-12-28 | Johns Hopkins University School Of Medicine | Growth differentiation factor-11 transgenic mice |
US5723125A (en) * | 1995-12-28 | 1998-03-03 | Tanox Biosystems, Inc. | Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide |
AU6274298A (en) | 1997-02-05 | 1998-08-25 | Johns Hopkins University School Of Medicine, The | Growth differentiation factor-8 |
US6696260B1 (en) * | 1997-08-01 | 2004-02-24 | The Johns Hopkins University School Of Medicine | Methods to identify growth differentiation factor (GDF) binding proteins |
US6656475B1 (en) * | 1997-08-01 | 2003-12-02 | The Johns Hopkins University School Of Medicine | Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
US6372454B2 (en) * | 1997-08-29 | 2002-04-16 | Human Genome Sciences, Inc. | Nucleic acid molecules encoding Follistatin-3 |
AU1276399A (en) | 1997-11-07 | 1999-05-31 | Genetics Institute Inc. | Neuronal uses of bmp-11 |
US5942420A (en) * | 1997-11-17 | 1999-08-24 | Millennium Biotherapeutics, Inc. | Molecules of the follistatin-related protein family and uses therefor |
US6369201B1 (en) * | 1998-02-19 | 2002-04-09 | Metamorphix International, Inc. | Myostatin multimers |
US6004937A (en) | 1998-03-09 | 1999-12-21 | Genetics Institute, Inc. | Use of follistatin to modulate growth and differentiation factor 8 [GDF-8] and bone morphogenic protein 11 [BMP-11] |
EP1075272B1 (fr) | 1998-05-06 | 2009-07-15 | Metamorphix, Inc. | Methodes de traitement du diabete par inhibition du gdf-8 |
WO2000011163A1 (fr) | 1998-08-20 | 2000-03-02 | Regeneron Pharmaceuticals, Inc. | Dcr5, proteine de fixation de proteines morphogenetiques osseuses, et ses applications |
MXPA01007366A (es) | 1999-01-21 | 2002-06-04 | Metamorphix Inc | Inhibidores de factores de crecimiento y diferenciacion y usos de los mismos. |
US20020004224A1 (en) * | 2000-02-29 | 2002-01-10 | Sheppard Paul O. | Kunitz domain polypeptide zkun8 |
WO2001064888A2 (fr) * | 2000-02-29 | 2001-09-07 | Zymogenetics, Inc. | Polypeptide zkun8 a domaine kunitz |
US7037501B2 (en) | 2001-01-04 | 2006-05-02 | Regents Of The University Of Minnesota | Myostatin immnoconjugate |
TWI329129B (en) | 2001-02-08 | 2010-08-21 | Wyeth Corp | Modified and stabilized gdf propeptides and uses thereof |
US7320789B2 (en) | 2001-09-26 | 2008-01-22 | Wyeth | Antibody inhibitors of GDF-8 and uses thereof |
EP1572909A4 (fr) | 2002-02-21 | 2007-06-06 | Wyeth Corp | Proteine contenant un domaine de follistatine |
MXPA04008149A (es) * | 2002-02-21 | 2005-06-17 | Wyeth Corp | Proteinas que contienen dominios de folistatina. |
JP2006507356A (ja) | 2002-09-16 | 2006-03-02 | ワイエス | ミオスタチンのメタロプロテアーゼ活性化およびミオスタチン活性の調節方法 |
AR047392A1 (es) | 2002-10-22 | 2006-01-18 | Wyeth Corp | Neutralizacion de anticuerpos contra gdf 8 y su uso para tales fines |
US20040223966A1 (en) * | 2002-10-25 | 2004-11-11 | Wolfman Neil M. | ActRIIB fusion polypeptides and uses therefor |
SI1581649T1 (sl) | 2002-12-20 | 2011-09-30 | Amgen Inc | Vezna sredstva, ki zavirajo miostatin |
-
2003
- 2003-02-21 EP EP03713568A patent/EP1572909A4/fr not_active Withdrawn
- 2003-02-21 CA CA002476887A patent/CA2476887A1/fr not_active Abandoned
- 2003-02-21 BR BRPI0307907-4A patent/BR0307907A2/pt not_active IP Right Cessation
- 2003-02-21 AU AU2003217612A patent/AU2003217612A1/en not_active Withdrawn
- 2003-02-21 MX MXPA04008150A patent/MXPA04008150A/es not_active Application Discontinuation
- 2003-02-21 WO PCT/US2003/005151 patent/WO2003072715A2/fr active Search and Examination
- 2003-02-21 KR KR10-2004-7012977A patent/KR20040094709A/ko not_active Application Discontinuation
- 2003-02-21 PL PL03375045A patent/PL375045A1/xx not_active Application Discontinuation
- 2003-02-21 IL IL16352503A patent/IL163525A0/xx unknown
- 2003-02-21 JP JP2003571403A patent/JP4429729B2/ja not_active Expired - Fee Related
- 2003-02-21 US US10/369,736 patent/US7192717B2/en not_active Expired - Fee Related
-
2004
- 2004-09-16 NO NO20043886A patent/NO20043886L/no not_active Application Discontinuation
-
2005
- 2005-01-04 US US11/028,058 patent/US7585835B2/en not_active Expired - Fee Related
-
2007
- 2007-01-31 US US11/669,531 patent/US7541154B2/en not_active Expired - Fee Related
-
2009
- 2009-08-13 US US12/540,606 patent/US7956038B2/en not_active Expired - Fee Related
- 2009-09-14 JP JP2009212565A patent/JP2010031018A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
NO20043886L (no) | 2004-09-16 |
BR0307907A2 (pt) | 2011-07-05 |
EP1572909A4 (fr) | 2007-06-06 |
WO2003072715A2 (fr) | 2003-09-04 |
US7956038B2 (en) | 2011-06-07 |
US7541154B2 (en) | 2009-06-02 |
MXPA04008150A (es) | 2005-06-17 |
PL375045A1 (en) | 2005-11-14 |
JP2005534616A (ja) | 2005-11-17 |
EP1572909A2 (fr) | 2005-09-14 |
US20030162714A1 (en) | 2003-08-28 |
US20070134258A1 (en) | 2007-06-14 |
US7585835B2 (en) | 2009-09-08 |
WO2003072715A3 (fr) | 2006-11-02 |
US20050106154A1 (en) | 2005-05-19 |
AU2003217612A1 (en) | 2003-09-09 |
US7192717B2 (en) | 2007-03-20 |
JP2010031018A (ja) | 2010-02-12 |
CA2476887A1 (fr) | 2003-09-04 |
US20100021462A1 (en) | 2010-01-28 |
WO2003072715A8 (fr) | 2005-01-13 |
JP4429729B2 (ja) | 2010-03-10 |
KR20040094709A (ko) | 2004-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL163525A0 (en) | A follistatin domain containing protein | |
EP1572934A4 (fr) | Domaine follistatine contenant des proteines | |
GB0226251D0 (en) | Acetylated protein | |
AU2003205623A8 (en) | Prion protein carrier-conjugates | |
ZA200406449B (en) | Follistatin domain containing proteins | |
GB0208089D0 (en) | Protein | |
GB0201808D0 (en) | Protein | |
PL376318A1 (en) | Protein modification | |
AU2003278718A8 (en) | Stars-a muscle-specification-binding protein | |
AU2003254669A8 (en) | Protein containing a burp domain | |
GB0220038D0 (en) | Novel Protein Design | |
GB0204735D0 (en) | Protein | |
GB0202748D0 (en) | Protein | |
GB0216601D0 (en) | Modified protein | |
GB0207141D0 (en) | Modified protein | |
GB0203156D0 (en) | Protein | |
GB0204476D0 (en) | Protein | |
GB0202668D0 (en) | Protein | |
GB0203040D0 (en) | Protein | |
GB0203155D0 (en) | Protein | |
GB0202666D0 (en) | Protein | |
GB0203157D0 (en) | Protein | |
GB0208091D0 (en) | Protein | |
GB0203159D0 (en) | Protein | |
GB0203160D0 (en) | Protein |